Category

News

Bioinformatics and project management

By | News | No Comments

As a company with close partnerships within medical centers and hospitals, GenomeScan is aware that reliable access to your sequencing data can be of crucial importance to your patients or your study. Thanks to our online platforms and Bio-IT infrastructure, our ongoing projects with laboratories in life science, healthcare and pharmaceutical industries proceed without interruption, despite the challenges many service…

Read More

Customer service and project management

By | News | No Comments

Project management via digital platforms The coronavirus outbreak is impacting the way we live, changing the way we work and transforming the way we communicate with each other. We know that the spread of COVID-19 does not remove the need to access high-quality scientific support and advice. Many laboratories in life science, healthcare and pharmaceutical industries are being affected by…

Read More

Statement from the CEO

By | News | No Comments

“In these unique circumstances, our team is dedicating its time, expertise and talents to support the healthcare and scientific communities and their scientific programs.”   GenomeScan has a crucial function and stays operational GenomeScan fully understands the measures announced recently by the Dutch government and is stepping up to the challenge ahead. Kees van den Berg, CEO of GenomeScan summarizes…

Read More

Maintaining quality and compliance

By | News | No Comments

The new coronavirus presents one of the most serious challenges we have ever faced. Laboratories are expected to provide consistent performance. Due to the COVID-19 outbreak and related uncertainties, it is quite a challenge to perform laboratory tests at the usual quality level. Quality and compliance at GenomeScan At GenomeScan, it is the task of the QA Department to make…

Read More

Information for visitors during the coronavirus crisis

By | News | No Comments

The current coronavirus situation is new and quite challenging for all of us. In this moment, at GenomeScan, we are committed to keeping our employees, customers and suppliers safe while still offering the best possible service. Visitor’s notice Under normal circumstances access to GenomeScan’s laboratory is limited to authorized individuals in order to safeguard laboratories and secure important research equipments…

Read More
NGS service equipment

Coronavirus precautions at GenomeScan

By | News | No Comments

GenomeScan’s activities during this unprecedent Coronavirus crisis GenomeScan is first and foremost concerned with the health of its staff, community and the larger public. The current coronavirus situation is new and quite challenging for all of us. In this moment, at GenomeScan, we are committed to keeping our employees, customers and suppliers safe, while still offering the best possible service….

Read More

Interview with GenomeScan’s CEO

By | News | No Comments

FASTER, BETTER, AFFORDABLE. BiotechNEWS has recently interviewed our CEO, Kees van den Berg. According to Kees, the future of diagnostics is all about personalized medicine. In this article (in Dutch), he describes the expansion of GenomeScan and the relationship with LUMC and ErasmusMC. He also highlights the current trends in NGS and comments on future developments in healthcare. Enjoy… Published…

Read More

GenomeScan joins ISO working group on food safety

By | News | No Comments

According to the International Organisation for Standardization (ISO), Next generation sequencing (NGS) provides rapid, economical and high-throughput access to microbial whole genome sequences (WGS) and is being applied to an expanding number of problems in food microbiology. WGS offers significant advantages over existing technologies (e.g., serology, pulsed field gel electrophoresis, antibiotic resistance phenotyping and sanger sequencing) in the detection of…

Read More

Prostate Cancer Research Network (TransPot)

By | Blog, News | One Comment

Translational Research Network for Prostate Cancer (TransPot) Today starts Movember (a combination of the English diminutive word for moustache, “mo”, and “November”), an annual event involving the growing of moustaches during the month of November to raise awareness of men’s health issues, such as prostate cancer, testicular cancer and men’s suicide. Prostate cancer is one of the most prevalent cancer…

Read More

Competitive, fast, and adaptable RNA Sequencing services

By | News | No Comments

RNA sequencing is an affordable and dependable tool driving R&D and clinical projects. To answer scientific challenges, GenomeScan develops innovative methods to analyze RNA samples. Minute populations of sorted cells or FFPE samples are no longer hampering progression of your project. Get direct access to a wide range of RNA-seq services under ISO/IEC 17015 accreditation. Our experienced scientific team can…

Read More

How to generate high-quality, alignable sequence data?

By | News | No Comments

Innovation Alert: Mid-read sequencing Sequencing of PE250 reads on the NovaSeq 6000   Printing a book of more than 2 billion pages, every two days. Illumina’s NovaSeq 6000 has made it possible to produce >6 Terabases of high-quality bases per sequencing run. This huge amount keeps the cost per base low and has allowed for the development of many new…

Read More

GenomeScan to offer two Bioinformatics PhD traineeships as part of the EU Horizon 2020 program

By | News | No Comments

Two EU-funded Consortium Grants for PhD training at GenomeScan GenomeScan has been granted two Marie Skłodowska-Curie Actions within the Innovative Training Network calls of the European Union-funded Horizon 2020 Program. These PhD traineeships are part of Horizon 2020 Grants acquired by two different Consortia where Academia and Industry collaborate closely together. Recruitment of PhD candidates with a focus on Bioinformatics…

Read More

Erasmus MC and LUMC to co-participate in GenomeScan

By | News | 2 Comments

Erasmus MC and Leiden University Medical Center to co-participate in GenomeScan BV and extend their collaboration in the field of molecular diagnostics and R&D   Erasmus MC (Rotterdam, The Netherlands) announced today the acquisition of shares of the fast-growing genomics service provider GenomeScan BV based in Leiden (The Netherlands). Together with the Leiden University Medical Center (LUMC), another shareholder in…

Read More